Deletions of chr9p21, which includes the tumor suppressor genes CDKN2A (p16) and CDKN2B, are associated with anaplastic meningiomas, poor prognosis, and aggressive clinical behavior [86,87,88,89,90,91]. This evidence concerns the gene CDKN2A and anaplastic meningioma.